[1]Baio J, Wiggins L, Christensen DL, et al. Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveill Summ, 2018, 67(6): 1-23
[2]Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet, 2014, 383(9920): 896-910
[3]Tick B, Bolton P, Happé F, et al. Heritability of autism spectrum disorders: a meta-analysis of twin studies. J Child Psychol Psychiatry, 2016, 57(5): 585-595
[4]Chess S. Autism in children with congenital rubella. J Autism Child Schizophr, 1971, 1(1): 33-47
[5]Meltzer A, Van de Water J. The role of the immune system in autism spectrum disorder. Neuropsychopharmacology, 2017, 42(1): 284-298
[6]Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature, 2015, 523(7560): 337-341
[7]Dunzendorfer S, Kaser A, Meierhofer C, et al. Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol, 2001, 166(4): 2167-2172
[8]Chavarría A, Cárdenas G. Neuronal influence behind the central nervous system regulation of the immune cells. Front Integr Neurosci, 2013, 7: 64
[9]Filiano AJ, Gadani SP, Kipnis J. How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci, 2017, 18(6): 375-384
[10]Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun, 2001, 15(1): 7-24
[11]Stevens B, Allen NJ, Vazquez LE, et al. The classical complement cascade mediates CNS synapse elimination. Cell, 2007, 131(6): 1164-1178
[12]Kipnis J. Immune system: The “seventh sense”. J Exp Med, 2018, 215(2): 397-398
[13]Brombacher TM, Nono JK, De Gouveia KS, et al. IL-13–mediated regulation of learning and memory. J Immunol, 2017, 198(7): 2681-2688
[14]Okunishi K, Dohi M, Nakagome K, et al. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol, 2005, 175(7): 4745-4753
[15]Rutella S, Bonanno G, Procoli A, et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++ IL-12low/neg accessory cells with dendritic-cell features. Blood, 2006, 108(1): 218-227
[16]Papaccio F, Della Corte CM, Viscardi G, et al. HGF/MET and the Immune System: Relevance for Cancer Immunotherapy. Int J Mol Sci, 2018, 19(11). pii: E3595
[17]Wu HH, Levitt P. Prenatal expression of MET receptor tyrosine kinase in the fetal mouse dorsal raphe nuclei and the visceral motor/sensory brainstem. Dev Neurosci, 2013, 35(1): 1-16
[18]Eagleson KL, Xie Z, Levitt P. The pleiotropic MET receptor network: circuit development and the neural-medical interface of autism. Biol Psychiatry, 2017, 81(5): 424-433
[19]Campbell DB, Sutcliffe JS, Ebert PJ, et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A, 2006, 103(45): 16834-16839
[20]Campbell DB, D'Oronzio R, Garbett K, et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol, 2007, 62(3): 243-250
[21]Campbell DB, Buie TM, Winter H, et al. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics, 2009, 123(3): 1018-1024
[22]Heuer L, Braunschweig D, Ashwood P, et al. Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression. Transl Psychiatry, 2011, 1(10): e48
[23]Shiina T, Hosomichi K, Inoko H, et al. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet, 2009, 54(1): 15-39
[24]Needleman LA, McAllister AK. The major histocompatibility complex and autism spectrum disorder. Dev Neurobiol, 2012, 72(10): 1288-1301
[25]Glynn MW, Elmer BM, Garay PA, et al. MHCⅠ negatively regulates synapse density during the establishment of cortical connections. Nat Neurosci, 2011, 14(4): 442-451
[26]Fourgeaud L, Davenport CM, Tyler CM, et al. MHC class I modulates NMDA receptor function and AMPA receptor trafficking. Proc Natl Acad Sci U S A, 2010, 107(51): 22278-22283
[27]Hartlehnert M, Derksen A, Hagenacker T, et al. Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class II. Sci Rep, 2017, 7(1): 12518
[28]Zhou J, Fonseca MI, Pisalyaput K, et al. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease. J Neurochem, 2008, 106(5): 2080-2092
[29]Thomas A, Gasque P, Vaudry D, et al. Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol, 2000, 12(7): 1015-1023
[30]Stellwagen D. The contribution of TNFα to synaptic plasticity and nervous system function. Adv Exp Med Biol, 2011, 691: 541-557
[31]Bennabi M, Gaman A, Delorme R, et al. HLA-class II haplotypes and Autism Spectrum Disorders. Sci Rep, 2018, 8(1): 7639
[32]Mostafa GA, Shehab AA, Al-Ayadhi LY. The link between some alleles on human leukocyte antigen system and autism in children. J Neuroimmunol, 2013, 255(1-2): 70-74
[33]Al-Hakbany M, Awadallah S, AL-Ayadhi L. The relationship of HLA class I and II alleles and haplotypes with autism: a case control study. Autism Res Treat, 2014, 2014: 242048
[34]Johnson WG, Buyske S, Mars AE, et al. HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. Arch Pediatr Adolesc Med, 2009, 163(6): 542-546
[35]Mostafa GA, Shehab AA. The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J Neuroimmunol, 2010, 223(1-2): 115-119
[36]Guerini FR, Bolognesi E, Chiappedi M, et al. An HLA-G(*)14bp insertion/deletion polymorphism associates with the development of autistic spectrum disorders. Brain Behav Immun, 2015, 44: 207-212
[37]Yasumura M, Yoshida T, Yamazaki M, et al. IL1RAPL1 knockout mice show spine density decrease, learning deficiency, hyperactivity and reduced anxiety-like behaviours. Sci Rep, 2014, 4: 6613
[38]Youngs EL, Henkhaus R, Hellings JA, et al. IL1RAPL1 gene deletion as a cause of X-linked intellectual disability and dysmorphic features. Eur J Med Genet, 2012, 55(1): 32-36
[39]Bhat SS, Ladd S, Grass F, et al. Disruption of the IL1RAPL1 gene associated with a pericentromeric inversion of the X chromosome in a patient with mental retardation and autism. Clin Genet, 2008, 73(1): 94-96
[40]Piton A, Michaud JL, Peng H, et al. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet, 2008, 17(24): 3965-3974
[41]Piton A, Gauthier J, Hamdan FF, et al. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry, 2011, 16(8): 867-880
[42]Butler MG, Rafi SK, Hossain W, et al. Whole exome sequencing in females with autism implicates novel and candidate genes. Int J Mol Sci, 2015, 16(1): 1312-1335
[43]Chatron N, Thibault L, Lespinasse J, et al. Genetic Counselling Pitfall: Co-Occurrence of an 11. 8-Mb Xp22 Duplication and an Xp21. 2 Duplication Disrupting IL1RAPL1. Mol Syndromol, 2017, 8(6): 325-330
[44]Carper RA, Courchesne E. Inverse correlation between frontal lobe and cerebellum sizes in children with autism. Brain, 2000, 123(4): 836-844
[45]Gambino F, Kneib M, Pavlowsky A, et al. IL1RAPL1 controls inhibitory networks during cerebellar development in mice. Eur J Neurosci, 2009, 30(8): 1476-1486
[46]Pavlowsky A, Gianfelice A, Pallotto M, et al. A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation. Curr Biol, 2010, 20(2): 103-115
[47]Yoshida T, Yasumura M, Uemura T, et al. IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase δ. J Neurosci, 2011, 31(38): 13485-13499
[48]Hayashi T, Yoshida T, Ra M, et al. IL1RAPL1 associated with mental retardation and autism regulates the formation and stabilization of glutamatergic synapses of cortical neurons through RhoA signaling pathway. PloS one, 2013, 8(6): e66254
[49]Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature, 2012, 485(7397): 237-241
[50]O'Roak BJ, Deriziotis P, Lee C, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet, 2011, 43(6): 585-589
[51]Gold WA, Krishnarajy R, Ellaway C, et al. Rett syndrome: a genetic update and clinical review focusing on comorbidities. ACS Chem Neurosci, 2017, 9(2): 167-176
[52]Zhao D, Mokhtari R, Pedrosa E, et al. Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress. Mol Autism, 2017, 8(1): 17
[53]Derecki NC, Cronk JC, Lu Z, et al. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature, 2012, 484(7392): 105-109
[54]Cronk JC, Derecki NC, Ji E, et al. Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli. Immunity, 2015, 42(4): 679-691
[55]Shulyakova N, Andreazza AC, Mills LR, et al. Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies. Front Cell Neurosci, 2017, 11: 58
[56]Van Esch H. MECP2 duplication syndrome. Mol Syndromol, 2012, 2(3-5): 128-136
[57]Bauer M, Kölsch U, Krüger R, et al. Infectious andimmunologic phenotype of MECP2 duplication syndrome. J Clin Immunol, 2015, 35(2): 168-181
[58]Yang T, Ramocki MB, Neul JL, et al. Overexpression of methyl-CpG binding protein 2 impairs TH1 responses. Sci Transl Med, 2012, 4(163): 163ra158
[59]Sawalha AH. Overexpression of methyl-CpG-binding protein 2 and autoimmunity: evidence from MECP2 duplication syndrome, lupus, MECP2 transgenic and Mecp2 deficient mice. Lupus, 2013, 22(9): 870-872
[60]Cronk JC, Herz J, Kim TS, et al. Influenza A induces dysfunctional immunity and death in MeCP2-overexpressing mice. JCI insight, 2017, 2(2): e88257
[61]Parikshak NN, Swarup V, Belgard TG, et al. Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism. Nature, 2016, 540(7633): 423-427
[62]Sun W, Poschmann J, Cruz-Herrera Del Rosario R, et al. Histone acetylome-wide association study of autism spectrum disorder. Cell, 2016, 167(5): 1385-1397. e11
[63]Garbett K, Ebert PJ, Mitchell A, et al. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis, 2008, 30(3): 303-311
[64]Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature, 2011, 474(7351): 380-384
[65]Ziats MN, Rennert OM. Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways. PloS one, 2011, 6(9): e24691
[66]Lintas C, Sacco R, Persico AM. Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiol Dis, 2012, 45(1): 57-68
[67]Guerini FR, Bolognesi E, Chiappedi M, et al. Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers. Brain Behav Immun, 2014, 36: 54-60
[68]Takei N, Nawa H. mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neurosci, 2014, 7: 28
[69]Powell JD, Pollizzi KN, Heikamp EB, et al. Regulation of immune responses by mTOR. Annu Rev Immunol, 2012, 30: 39-68
[70]Costa-Mattioli M, Monteggia LM. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci, 2013, 16(11): 1537-1543
[71]Ricciardi S, Boggio EM, Grosso S, et al. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet, 2011, 20(6): 1182-1196 |
